All News

Found 539,658 articles

• Evotec And Helmholtz Centre Joining Platforms And Forces For Novel Antibiotics

  2/20/2019

  Evotec and helmholtz aim to jointly develop cystobactamid derivatives into a new class of broad spectrum antiobiotics targeting high-priority pathogens

• Hygieia Receives 510(k) Clearance from FDA for Phone App That Enhances Company's d-Nav Insulin Guidance Service

  2/20/2019

  First Insulin-Management App Able to Titrate All Types of Insulin Regimens for People with Type 2 Diabetes and Connect To Any Glucose Meter That Shares Data with the Cloud

• Performance Health Appoints Francis X. Dirksmeier as Chief Executive Officer

  2/20/2019

  Brings Proven Track Record of Health Care Industry Leadership and Operational Excellence in Medical Product Manufacturing and Distribution

• NanoSphere Signs Definitive Licensing Agreement in Oregon

  2/20/2019

  Partnership with Cascade Pure Brings Disruptive Evolve Formulas Technology to $550 Million Oregon Cannabis Market

• Bio-Techne To Present At The 8th Annual SVB Leerink Global Healthcare Conference

  2/20/2019

  Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer will present at the 8th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 27th, 2019, at 10:30 a.m. EST.

• New Study in Mice Reveals Unexpected Place for Learning, Memory in the Brain

  2/20/2019

  Columbia research demonstrates that the brain's primitive sensory region also participates in sophisticated learning

• GNC Campaign Reminds Consumers that Not All Diets are Created Equal

  2/20/2019

  Expanded Solutions Designed to Offer Greater Customization for Individual Goals

• National Hearing Health Campaign Unifies Hundreds of Hearing Health Centers

  2/20/2019

   Hundreds of hearing health organizations have unified in support of a common cause, launching The Campaign for Better Hearing in the United States.

• MedCore Partners and The National Realty Group (TNRG) Announce the Start of Construction on Fountainwood at Lake Houston

  2/20/2019

  Fountainwood will open for business in late summer 2020.

• Toronto Pearson and St. John Ambulance Therapy Dog Program Bring Therapy Dogs to YYZ to Enhance the Passenger Experience

  2/20/2019

  Fifteen Therapy Dog Teams Join the Welcome Team Volunteer Program at Canada's Largest Airport

• Abbott and Novo Nordisk Enter Partnership to Provide Integrated Digital Solution to People with Diabetes Using Insulin

  2/20/2019

  Abbott (NYSE: ABT) and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system (FreeStyle LibreLinkii mobile app and LibreViewiii cloud-based system).

• Human Rights Organizers Encourage Employees to Blow the Whistle on Unethical Tech

  2/20/2019

  Today, Fight for the Future launched a website and video ad campaign that directly calls on employees of big tech companies to blow the whistle on unethical uses of technology.

• HFSA Partners With XpertDox To Launch XpertTrial, A Clinical Trial Recruitment Platform, To Accelerate Medical Research

  2/20/2019

  The XpertTrial platform will provide patients and providers with the most up-to-date information regarding actively-recruiting, U.S.-based heart failure related clinical trials

• DataPath Employee Engagement Program Garners Video Gold Award

  2/20/2019

  Captain Contributor is designed to help third party benefits administrators educate employees about Flexible Spending Accounts, Health Savings Accounts, COBRA, and similar employee benefits.

• People With Diabetes Using One Drop & Afrezza Significantly Lower A1c In 3 Months

  2/20/2019

  One Drop announces RCT study results demonstrating a -0.93% absolute A1c improvement among people with type 2 diabetes using One Drop's digital therapeutic solution and Afrezza

• Liquid I.V. Leverages Breakthrough Science of Cellular Transport Technology to Create Groundbreaking Sleep Aid

  2/20/2019

  The new product launch commences the company's expansion from the fastest-growing hydration company in the world, to 360-degree wellness brand.

• Blood is Every Business's Business

  2/20/2019

  Urgent First Aid™ reminds businesses that blood can be a risk and a liability for employers in any and every field.

• BerGenBio ASA Publishes Annual Report for 2018

  2/20/2019

  The report is attached and available for download at www.bergenbio.com in the section: Investors/Financial Reports.

• The Michael J. Fox Foundation and The Silverstein Foundation for Parkinson's with GBA Grant Nearly $3 Million to Studies into Disease's Most Common Known Genetic Contributor

  2/20/2019

  The Michael J. Fox Foundation and The Silverstein Foundation for Parkinson's with GBA teamed up on this funding program to leverage resources and streamline review

• Omeros Corporation Announces USAN and INN Selection of Nonproprietary Name for OMS721

  2/20/2019

  Omeros Corporation (Nasdaq: OMER) today announced that, as the company prepares for planned commercialization of OMS721, the United States Adopted Names (USAN) Council, in consultation with the World Health Organization’s International Nonproprietary Names (INN) Expert Committee, has selected for the drug the nonproprietary name “narsoplimab.”